Grifols, S.A.

General ticker "GIFOF" information:

  • Sector: Health Care
  • Industry: Drug Manufacturers - General
  • Capitalization: $6.0B (TTM average)

Grifols, S.A. follows the US Stock Market performance with the rate: 27.6%.

Estimated limits based on current volatility of 0.0%: low 8.85$, high 8.85$

Factors to consider:

  • Company pays dividends (semi-annually): last record date 2025-08-12, amount 0.18$ (Y4.07%)
  • Total employees count: 157 as of 2010

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

  • 2025-12-31 to 2026-12-31 estimated range: [7.67$, 12.23$]
  • 2026-12-31 to 2027-12-31 estimated range: [8.84$, 13.77$]

Financial Metrics affecting the GIFOF estimates:

  • Positive: with PPE of 10.9 at the end of fiscal year the price was low
  • Positive: Operating cash flow per share per price, % of 20.31 > 12.96
  • Positive: 7.68 < Operating profit margin, % of 16.62
  • Positive: -14.24 < Investing cash flow per share per price, % of -11.23
  • Negative: Interest expense per share per price, % of 12.18 > 3.29
  • Negative: 19.49 < Shareholder equity ratio, % of 26.74 <= 42.60
  • Positive: Industry earnings per price (median), % of 6.05 > 4.54
  • Positive: Inventory ratio change, % of -2.14 <= -0.75
  • Negative: Industry operating cash flow per share per price (median), % of 6.51 <= 10.31

Similar symbols

Short-term GIFOF quotes

Long-term GIFOF plot with estimates

Financial data

YTD 2023-12-31 2024-12-31 2025-12-31
Operating Revenue €6,591.98MM €7,212.38MM €7,521.39MM
Operating Expenses €5,792.58MM €6,020.37MM €6,271.35MM
Operating Income €799.40MM €1,192.02MM €1,250.03MM
Non-Operating Income €-575.38MM €-748.02MM €-635.18MM
Interest Expense €516.06MM €739.94MM €628.00MM
R&D Expense €395.28MM €384.04MM €425.86MM
Income(Loss) €224.02MM €444.00MM €614.85MM
Taxes €43.35MM €231.19MM €114.57MM
Profit(Loss)* €59.31MM €156.92MM €401.74MM
Stockholders Equity €5,827.17MM €5,883.73MM €5,269.79MM
Inventory €3,459.28MM €3,560.10MM €3,294.62MM
Assets €21,441.05MM €21,405.24MM €19,703.98MM
Operating Cash Flow €208.28MM €902.17MM €1,046.61MM
Capital expenditure €295.42MM €371.37MM €264.90MM
Investing Cash Flow €-397.64MM €886.67MM €-578.78MM
Financing Cash Flow €186.04MM €-1,358.71MM €-528.80MM
Earnings Per Share** €0.09 €0.22 €0.58

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.